Stellungnahme des Berufsverbandes der Augenärzte Deutschlands und der Deutschen Ophthalmologischen Gesellschaft zu physikalischen Therapieformen des trockenen Auges

Berufsverband der Augenärzte Deutschlands e. V.; Deutsche Ophthalmologische Gesellschaft

doi:10.1055/a-0597-9833

Klinische Monatsblätter für Augenheilkunde, Table of Contents

Klin Monbl Augenheilkd 2018; 235(06): 743-746
DOI: 10.1055/a-0597-9833

Statement

Georg Thieme Verlag KG Stuttgart · New York

Stellungnahme des Berufsverbandes der Augenärzte Deutschlands und der Deutschen Ophthalmologischen Gesellschaft zu physikalischen Therapieformen des trockenen Auges^[*]

Stand Juli 2017 Berufsverband der Augenärzte Deutschlands e. V. , Deutsche Ophthalmologische Gesellschaft

Abstract

Full Text

References

Literatur
1 Alghamdi YA, Camp A, Feuer W. et al. Compliance and subjective patient responses to eyelid hygiene. Eye Contact Lens 2017; 43: 213-217 doi:10.1097/ICL.0000000000000258
2 Blackie CA, Carlson AN, Korb DR. Treatment for meibomian gland dysfunction and dry eye symptoms with a single-dose vectored thermal pulsation: a review. Curr Opin Ophthalmol 2015; 26: 306-313 doi:10.1097/ICU.0000000000000165
3 Blackie CA, Coleman CA, Holland EJ. The sustained effect (12 months) of a single-dose vectored thermal pulsation procedure for meibomian gland dysfunction and evaporative dry eye. Clin Ophthalmol 2016; 10: 1385-1396 doi:10.2147/OPTH.S109663
4 Bron AJ, Benjamin L, Snibson GR. Meibomian gland disease. Classification and grading of lid changes. Eye (Lond) 1991; 5: 395-411 doi:10.1038/eye.1991.65
5 Craig JP, Chen YH, Turnbull PR. Prospective trial of intense pulsed light for the treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci 2015; 56: 1965-1970 doi:10.1167/iovs.14-15764
6 Finis D, Hayajneh J, Konig C. et al. Evaluation of an automated thermodynamic treatment (LipiFlow^®) system for meibomian gland dysfunction: a prospective, randomized, observer-masked trial. Ocul Surf 2014; 12: 146-154 doi:10.1016/j.jtos.2013.12.001
7 Finis D, König C, Hayajneh J. et al. Six-month effects of a thermodynamic treatment for MGD and implications of meibomian gland atrophy. Cornea 2014; 33: 1265-1270
8 Galor A, Kumar N, Feuer W. et al. Environmental factors affect the risk of dry eye syndrome in a United States veteran population. Ophthalmology 2014; 121: 972-973.e1 doi:10.1016/j.ophtha.2013.11.036
9 Geerling G, Tauber J, Baudouin C. et al. The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci 2011; 52: 2050-2064 doi:10.1167/iovs.10-6997g
10 Gipson IK. Age-related changes and diseases of the ocular surface and cornea. Invest Ophthalmol Vis Sci 2013; 54: ORSF48-ORSF53 doi:10.1167/iovs.13-12840
11 Goldberg DJ. Current trends in intense pulsed light. J Clin Aesthet Dermatol 2012; 5: 45-53
12 Green-Church KB, Butovich I, Willcox M. et al. The international workshop on meibomian gland dysfunction: report of the subcommittee on tear film lipids and lipid-protein interactions in health and disease. Invest Ophthalmol Vis Sci 2011; 52: 1979-1993 doi:10.1167/iovs.10-6997d
13 Greiner JV. Long-term (3 year) effects of a single thermal pulsation system treatment on meibomian gland function and dry eye symptoms. Eye Contact Lens 2016; 42: 99-107 doi:10.1097/ICL.0000000000000166
14 Kawana S, Ochiai H, Tachihara R. Objective evaluation of the effect of intense pulsed light on rosacea and solar lentigines by spectrophotometric analysis of skin color. Dermatol Surg 2007; 33: 449-454
15 Key JE. A comparative study of eyelid cleaning regimens in chronic blepharitis. CLAO J 1996; 22: 209-212
16 Lane SS, Dubiner HB, Epstein RJ. et al. A new system, the LipiFlow, for the treatment of meibomian gland dysfunction. Cornea 2012; 31: 396-404 doi:10.1097/ICO.0b013e318239aaea
17 McCulley JP, Shine WE. Changing concepts in the diagnosis and management of blepharitis. Cornea 2000; 19: 650-658
18 Nichols KK, Foulks GN, Bron AJ. et al. The international workshop on meibomian gland dysfunction: executive summary. Invest Ophthalmol Vis Sci 2011; 52: 1922-1929 doi:10.1167/iovs.10-6997a
19 Ruprecht K. Incidence of the complaint of frequent “sandy sensations” in the eyes. Contact Intraocul Lens Med J 1978; 4: 41-44
20 Schaumberg DA, Sullivan DA, Buring JE. et al. Prevalence of dry eye syndrome among US women. Am J Ophthalmol 2003; 136: 318-326 doi:10.1016/S0002-9394(03)00218-6
21 Schroeter CA, Haaf-Von Below S, Neumann HA. Effective treatment of rosacea using intense pulsed light systems. Dermatol Surg 2005; 31: 1285-1289
22 Smith RE, Flowers jr. CW. Chronic blepharitis: a review. CLAO J 1995; 21: 200-207
23 Tong L, Chaurasia SS, Mehta JS. et al. Screening for meibomian gland disease: its relation to dry eye subtypes and symptoms in a tertiary referral clinic in Singapore. Invest Ophthalmol Vis Sci 2010; 51: 3449-3454 doi:10.1167/iovs.09-4445
24 Uchino M, Uchino Y, Dogru M. et al. Dry eye disease and work productivity loss in visual display users: the Osaka study. Am J Ophthalmol 2014; 157: 294-300 doi:10.1016/j.ajo.2013.10.014
25 Um SB, Kim NH, Lee HK. et al. Spatial epidemiology of dry eye disease: findings from South Korea. Int J Health Geogr 2014; 13: 31 doi:10.1186/1476-072X-13-31
26 Vegunta S, Patel D, Shen JF. Combination therapy of intense pulsed light therapy and meibomian gland expression (IPL/MGX) can improve dry eye symptoms and meibomian gland function in patients with refractory dry eye: a retrospective analysis. Cornea 2016; 35: 318-322 doi:10.1097/ICO.0000000000000735
27 Vehof J, Kozareva D, Hysi PG. et al. Prevalence and risk factors of dry eye disease in a British female cohort. Br J Ophthalmol 2014; 98: 1712-1717 doi:10.1136/bjophthalmol-2014-305201
28 Viso E, Rodriguez-Ares MT, Gude F. Prevalence of and associated factors for dry eye in a Spanish adult population (the Salnes Eye Study). Ophthalmic Epidemiol 2009; 16: 15-21 doi:10.1080/09286580802228509
29 Yamada M, Mizuno Y, Shigeyasu C. Impact of dry eye on work productivity. Clinicoecon Outcomes Res 2012; 4: 307-312 doi:10.2147/CEOR.S36352

Stellungnahme des Berufsverbandes der Augenärzte Deutschlands und der Deutschen Ophthalmologischen Gesellschaft zu physikalischen Therapieformen des trockenen Auges[*]

Stellungnahme des Berufsverbandes der Augenärzte Deutschlands und der Deutschen Ophthalmologischen Gesellschaft zu physikalischen Therapieformen des trockenen Auges^[*]